Skates SJ - Search Results

1

Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.

Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC. Ye B, et al. Among authors: skates sj. Clin Cancer Res. 2003 Aug 1;9(8):2904-11. Clin Cancer Res. 2003. PMID: 12912935

2

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

Skates SJ, Xu FJ, Yu YH, Sjövall K, Einhorn N, Chang Y, Bast RC Jr, Knapp RC. Skates SJ, et al. Cancer. 1995 Nov 15;76(10 Suppl):2004-10. doi: 10.1002/1097-0142(19951115)76:10+<2004::aid-cncr2820761317>3.0.co;2-g. Cancer. 1995. PMID: 8634992

3

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.

Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW. Mok SC, et al. J Natl Cancer Inst. 2001 Oct 3;93(19):1458-64. doi: 10.1093/jnci/93.19.1458. J Natl Cancer Inst. 2001. PMID: 11584061

4

Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Kim JH, et al. Among authors: skates sj. JAMA. 2002 Apr 3;287(13):1671-9. doi: 10.1001/jama.287.13.1671. JAMA. 2002. PMID: 11926891

5

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

Skates SJ, Menon U, MacDonald N, Rosenthal AN, Oram DH, Knapp RC, Jacobs IJ. Skates SJ, et al. J Clin Oncol. 2003 May 15;21(10 Suppl):206s-210s. doi: 10.1200/JCO.2003.02.955. J Clin Oncol. 2003. PMID: 12743136

6

Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.

Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC. Kim JH, et al. Among authors: skates sj. Clin Cancer Res. 2003 Oct 15;9(13):4782-91. Clin Cancer Res. 2003. PMID: 14581349

7

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.

Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Schorge JO, et al. Among authors: skates sj. Clin Cancer Res. 2004 May 15;10(10):3474-8. doi: 10.1158/1078-0432.CCR-03-0365. Clin Cancer Res. 2004. PMID: 15161704

8

Blood and urine markers for ovarian cancer: a comprehensive review.

Terry KL, Sluss PM, Skates SJ, Mok SC, Ye B, Vitonis AF, Cramer DW. Terry KL, et al. Among authors: skates sj. Dis Markers. 2004;20(2):53-70. doi: 10.1155/2004/241982. Dis Markers. 2004. PMID: 15322314 Free PMC article. Review. No abstract available.

9

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC Jr. Skates SJ, et al. J Clin Oncol. 2004 Oct 15;22(20):4059-66. doi: 10.1200/JCO.2004.03.091. Epub 2004 Sep 20. J Clin Oncol. 2004. PMID: 15381683

10

Molecular markers for early detection of renal carcinoma: investigative approach.

Skates S, Iliopoulos O. Skates S, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6296S-301S. doi: 10.1158/1078-0432.CCR-050010. Clin Cancer Res. 2004. PMID: 15448020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page